The Federal Circuit revived a lawsuit against Medtronic Inc. over guide catheter technology Monday, ruling that a district ...

Medtronic Plc’s (NYSE:MDT) Neurosurgery unit on Thursday said it is recalling the Duet External Drainage and Monitoring System (EDMS) catheter tubing due to a potential for the catheter ...

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the ...

Medtronic highlighted results from its PULSED AF clinical trial, which demonstrated the catheter isolated pulmonary veins with an average energy delivery time of 30 seconds. The device is designed ...

The firm's analysis anticipates the approval of Medtronic’s second Pulsed Field Ablation (PFA) catheter, Sphere-9, by the FDA before the end of the year. The approval is expected to ...

Medtronic (MDT) is a billion-dollar global leader in medical technology, offering medical devices and therapies to more than 74 million people across 150+ countries. Medtronic—derived from ...

Shares of Medtronic PLC climbed toward a three-month high in early Tuesday trading, after the medical-technology company topped fiscal first-quarter earnings expectations, amid strength in its ...

Medical device giant Medtronic (NYSE: MDT) has been somewhat of a stock market laggard over the past five years, partly due to pandemic-related disruptions. Even beyond this global issue ...

Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price stagnation since 2018. Despite recent improvements in performance, Medtronic ...

Medtronic has been expanding its operations. In just the past year, it has obtained approximately 130 product approvals in many key markets. From catheters to neurostimulators to continuous ...

Medtronic delivered a strong first-quarter earnings report. The company benefits from continued market adoption of several new product launches over the past year. The stock looks attractive ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...